Expand HRMY Menu
HRMY MENU

HRMY Latest Press Releases

-- October 1, 2026 --

Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days Globe Newswire 8:05 AM

-- September 3, 2026 --

Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress Globe Newswire 8:05 AM

-- August 27, 2026 --

Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference Globe Newswire 8:05 AM

-- August 6, 2026 --

Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium Globe Newswire 8:05 AM

-- August 4, 2026 --

Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile Globe Newswire 7:30 AM

-- July 21, 2026 --

Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026 Globe Newswire 8:05 AM

-- July 16, 2026 --

Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition Business Wire 8:30 AM

-- June 11, 2026 --

Paragon Advances Registration-Ready CNS Asset Addressing Important Unmet Need and Closes Sale to Teva Pharmaceutical Business Wire 3:03 PM
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting Business Wire 8:05 AM

-- May 27, 2026 --

Harmony Biosciences to Participate in Upcoming Investor Conferences Business Wire 8:05 AM

-- May 7, 2026 --

Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities Business Wire 7:30 AM
Market Data Delayed 15 Minutes